Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

A vaccine strategy that induces protective immunity against heroin

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Stowe, G. N.
  • Vendruscolo, L. F.
  • Edwards, S.
  • Schlosburg, J. E.
  • Misra, K. K.
  • Schulteis, G.
  • Mayorov, A. V.
  • Zakhari, J. S.
  • Koob, George
  • Janda, Kim

publication date

  • July 2011

journal

  • Journal of Medicinal Chemistry  Journal

abstract

  • Heroin addiction is a wide-reaching problem with a spectrum of damaging social consequences. A vaccine capable of blocking heroin's effects could provide a long-lasting and sustainable adjunct to heroin addiction therapy. Heroin, however, presents a particularly challenging immunotherapeutic target, as it is metabolized to multiple psychoactive molecules. To reconcile this dilemma, we examined the idea of a singular vaccine with the potential to display multiple drug-like antigens; thus two haptens were synthesized, one heroin-like and another morphine-like in chemical structure. A key feature in this approach is that immunopresentation with the heroin-like hapten is thought to be immunochemically dynamic such that multiple haptens are simultaneously presented to the immune system. We demonstrate the significance of this approach through the extremely rapid generation of robust polyclonal antibody titers with remarkable specificity. Importantly, both the antinociceptive effects of heroin and acquisition of heroin self-administration were blocked in rats vaccinated using the heroin-like hapten.

subject areas

  • Animals
  • Antibody Specificity
  • Cattle
  • Drug Carriers
  • Enzyme-Linked Immunosorbent Assay
  • Haptens
  • Hemocyanin
  • Heroin
  • Heroin Dependence
  • Hot Temperature
  • Immunoconjugates
  • Male
  • Molecular Structure
  • Morphine
  • Narcotics
  • Pain
  • Psychotropic Drugs
  • Rats
  • Rats, Wistar
  • Secondary Prevention
  • Self Administration
  • Serum Albumin, Bovine
  • Structure-Activity Relationship
  • Touch
  • Vaccines
scroll to property group menus

Identity

PubMed Central ID

  • PMC3142939

International Standard Serial Number (ISSN)

  • 0022-2623

Digital Object Identifier (DOI)

  • 10.1021/jm200461m

PubMed ID

  • 21692508
scroll to property group menus

Additional Document Info

start page

  • 5195

end page

  • 5204

volume

  • 54

issue

  • 14

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support